Skip to content

PAR Technology PAR Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By segment

See full
Restaurant and Retail25%+31.6%

Other financials

Income statement

See full
Revenue$124.0M+19.4%
Gross profit$54.5M+12.7%
Operating income-$13.9M+11.8%
Net income-$16.2M+33.6%
EPS (diluted)-$0.39+35.0%

Balance sheet

See full
Cash & equivalents$90.8M-17.3%
Total debt$433.8M+3.3%
Total equity$826.4M-3.0%
Total assets$1.4B+0.7%

Cash flow

See full
Operating cash flow-$16.6M+3.1%
CapEx$321.0K-22.3%
Free cash flow-$17.0M+3.5%

Valuation

See full
Market cap$656.64M-74.4%
Enterprise value$999.68M-65.3%
P/S1.4×-5.3×

Profitability

See full
Gross margin42.9%-1.0pp
Operating margin-14.1%-2.4pp
Net margin-16%-20.5pp
FCF margin-14.3%-4.0pp

Returns & leverage

See full
Return on equity-9.1%-11.6pp
Debt / equity0.5×0.0×
Current ratio2.1×+0.1×